HIGHLIGHTS
- who: I-Jung Tsai and colleagues from the Taipei Medical University, Taipei, Taiwan have published the research: Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease, in the Journal: Diagnostics 2022, 2269 of 15/06/2017
- what: The study demonstrated the combination of autoantibodies against oxidative modification may improve the model performance. diagnostics12102269 InIn thisthis study, the authors examined the diagnostic performance of four HNE-modified peptides study, the authors examined the diagnostic performance of four HNE-modified inpeptides CAD thatinhad been previously reported in patients with RA . The authors firstly reported . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.